ImpediMed Limited
IPDQF
$0.01
$0.00-17.65%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.27% | -13.18% | -15.81% | -12.20% | -8.44% |
| Total Depreciation and Amortization | -67.87% | -49.35% | 11.88% | 106.60% | 209.44% |
| Total Amortization of Deferred Charges | 129.99% | 129.99% | 129.99% | 51.41% | -15.16% |
| Total Other Non-Cash Items | 237.38% | 250.89% | 273.01% | -97.74% | -131.90% |
| Change in Net Operating Assets | 168.68% | 168.68% | 168.68% | 932.41% | 253.37% |
| Cash from Operations | 17.24% | 17.19% | 16.01% | -10.73% | -47.77% |
| Capital Expenditure | -- | -43.94% | 28.17% | 82.38% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 77.85% | 83.29% | 86.02% | 75.16% | 68.61% |
| Cash from Investing | 74.07% | 81.08% | 84.52% | 75.45% | 70.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 19.26% | 15.34% | 11.53% | 6.26% | 0.86% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -8,379.03% | -2,969.35% | -16.53% | 100.00% |
| Cash from Financing | 4,286.08% | 3,540.53% | 2,840.14% | -55.21% | -101.61% |
| Foreign Exchange rate Adjustments | -253.32% | -249.40% | -231.97% | 82.47% | 334.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.21% | 96.19% | 87.43% | -120.82% | -270.37% |